APA

Lieu C. H., Klauck P. J., Henthorn P. K., Tentler J. J., Tan A., Spreafico A., Selby H. M., Britt B. C., Bagby S. M., Arcaroli J. J., Messersmith W. A., Pitts T. M. & Eckhardt S. G. (20160812). Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts. : Oncotarget.

Chicago

Lieu Christopher H, Klauck Peter J, Henthorn Patrick K, Tentler John J, Tan Aik-Choon, Spreafico Anna, Selby Heather M, Britt Blair C, Bagby Stacey M, Arcaroli John J, Messersmith Wells A, Pitts Todd M and Eckhardt S Gail. 20160812. Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts. : Oncotarget.

Harvard

Lieu C. H., Klauck P. J., Henthorn P. K., Tentler J. J., Tan A., Spreafico A., Selby H. M., Britt B. C., Bagby S. M., Arcaroli J. J., Messersmith W. A., Pitts T. M. and Eckhardt S. G. (20160812). Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts. : Oncotarget.

MLA

Lieu Christopher H, Klauck Peter J, Henthorn Patrick K, Tentler John J, Tan Aik-Choon, Spreafico Anna, Selby Heather M, Britt Blair C, Bagby Stacey M, Arcaroli John J, Messersmith Wells A, Pitts Todd M and Eckhardt S Gail. Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts. : Oncotarget. 20160812.